---
title: "Lionco: Subsidiary Lionco Pharmaceutical's product, injectable cefazolin sodium, is expected to be selected for national centralized drug procurement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263233220.md"
description: "Lionco announced that its wholly-owned subsidiary Lionco Pharmaceutical's injectable cefazolin sodium product is expected to be selected for the national centralized drug procurement, with an estimated sales revenue of 23.0089 million yuan in 2024, accounting for 6.06% of the company's annual operating income. If the contract is successfully signed, it will help expand the market and enhance brand influence, but there is uncertainty regarding the subsequent contract signing. The company will closely monitor the progress and fulfill its information disclosure obligations"
datetime: "2025-10-29T07:58:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263233220.md)
  - [en](https://longbridge.com/en/news/263233220.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263233220.md)
---

# Lionco: Subsidiary Lionco Pharmaceutical's product, injectable cefazolin sodium, is expected to be selected for national centralized drug procurement

Lionco announced that its wholly-owned subsidiary, Lionco Pharmaceutical, participated in the 11th national centralized procurement organized by the National Organization for Drug Procurement Office, and its product, injectable cefazolin sodium, is expected to be selected. The sales revenue of this product in 2024 is projected to be 23.0089 million yuan, accounting for 6.06% of the company's operating income for 2024. If selected and a purchase and sales contract is signed and implemented, it will promote the market expansion of the company's related products and enhance brand influence, positively impacting future performance. However, there is currently uncertainty regarding the signing of contracts and other follow-up matters, and the company will closely monitor progress and fulfill its information disclosure obligations

### Related Stocks

- [603669.CN](https://longbridge.com/en/quote/603669.CN.md)

## Related News & Research

- [NYC Health and Hospitals says hackers stole medical data and fingerprints during breach affecting at least 1.8 million people](https://longbridge.com/en/news/286799449.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Dunkin' To Give Away 1 Mln Free Coffees For A Day](https://longbridge.com/en/news/286964019.md)
- [11:48 ETInventHelp Inventor Develops New Remote Control Finder (TKA-458)](https://longbridge.com/en/news/286941635.md)
- [BioInvent to Host Virtual KOL Event to Discuss BI-1808 for the Treatment of Ovarian Cancer, on May 27, 2026](https://longbridge.com/en/news/287043048.md)